Research Article
Elevated Serum IL-17 Expression at Cessation Associated with Graves’ Disease Relapse
Table 2
T helper cell cytokines at diagnosis/cessation in GD patients with or without relapse.
| Laboratory tests | Relapse | value | Yes () | No () |
| Cytokines at diagnosis | | | | IL-4 (pg/mL) | 21.1 ± 5.8 | 19.9 ± 6.1 | 0.29 | IL-17 (pg/mL) | 10.9 ± 3.7 | 10.1 ± 3.2 | 0.22 | IFN-γ (pg/mL) | 130.4 ± 65.4 | 124.5 ± 55.8 | 0.60 | Cytokines at cessation | | | | IL-4 (pg/mL) | 15.1 ± 5.9 | 12.8 ± 4.7 | 0.022 | IL-17 (pg/mL) | 8.9 ± 3.1 | 7.1 ± 2.7 | 0.001 | IFN-γ (pg/mL) | 122.4 ± 54.9 | 118.9 ± 51.7 | 0.73 |
|
|
GD: Graves’ disease; IL-4: interleukin-4; IL-17: interleukin-17; IFN- γ: interferon- γ. values were calculated by Student’s t-test. . |